Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Surgical Treatment in Pediatric OSA
NCT05651750Phase 4Unknown
- Sponsor
- Shamir Medical Center
- Start
- Nov 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast, fluticasone in obstructive sleep apnea (OSA), Adenotonsillar hypertrophy (ATH), sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
montelukastfluticasone
03
Conditions
obstructive sleep apnea (OSA)Adenotonsillar hypertrophy (ATH)
Beyond the preview
Go deeper on NCT05651750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05651750.